{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:48:58Z","timestamp":1780400938380,"version":"3.54.1"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences, Iran","doi-asserted-by":"publisher","award":["15527"],"award-info":[{"award-number":["15527"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>CRM197, a non-toxic diphtheria toxin variant, is widely used as a\npolysaccharide carrier in a variety of conjugate vaccines and also exhibits antitumor activity. CRM197\ncommercial production is limited due to the low yield of Corynebacterium diphtheriae C7\n(197) tox-. Developing an efficient method for recombinant CRM197 production reduces production\ncosts and is critical for expanding the application coverage of related medical products and basic research.\nEscherichia coli is a frequently used host for heterologous protein synthesis. However, the\nprimary limitation of this system is the inclusion body formation and the low yield of active protein\nrecovery.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>As a result, we attempted to produce CRM197 in the soluble form in E. coli using a\nsmall ubiquitin-related modifier (SUMO) tag fusion and an expression strategy optimized for protein\nproduction.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>CRM197 was expressed intracellularly in E. coli BL21 (DE3) with its N-terminus fused\nto a SUMO tag preceded by a histidine tag (HSCRM197). To improve the solubility of HSCRM197\nin E. coli, a response surface method (RSM) experimental design was used based on three\nfactors: expression temperature, inducer concentration, and sorbitol inclusion in the culture medium.\nMetal affinity chromatography was used to purify HSCRM197, and the SUMO tag was removed\nusing the SUMO protease's catalytic domain. After adsorbing the SUMO tag on a Ni-NTA\ncolumn, CRM197 was obtained. DNA degradation activity was determined for both HSCRM197\nand CRM197.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>When HSCRM197 was expressed in E. coli under common expression conditions (37\u00baC,\n1000 \u03bcM inducer), 15.4% of the protein was found in the cellular soluble fraction. However, when\nthe RSM-derived expression conditions were used (30\u00baC, 510 \u03bcM inducer, and 200 mM sorbitol),\nthe obtained HSCRM197 was almost completely soluble (96.5% solubility), and the system productivity\nwas 32.67 \u03bcg ml-1 h-1. HSCRM197 and CRM197 both exhibited nuclease activity. However,\nthe activity of CRM197 was greater than that of HSCRM197.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These findings established the utility of the method developed in this study to produce\nCRM197 for medical applications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866529666220209155738","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T10:04:48Z","timestamp":1644487488000},"page":"350-359","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Soluble Diphtheria Toxin Variant, CRM 197 was Obtained in <i>Escherichia\ncoli<\/i> at High Productivity Using SUMO Fusion and an Adjusted\nExpression Strategy"],"prefix":"10.2174","volume":"29","author":[{"given":"Shirin","family":"Tarahomjoo","sequence":"first","affiliation":[{"name":"Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO),\nKaraj 31975\/148, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Bandehpour","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences,\nTehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Aghaebrahimian","sequence":"additional","affiliation":[{"name":"Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO),\nKaraj 31975\/148, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salimeh","family":"Ahangaran","sequence":"additional","affiliation":[{"name":"Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO),\nKaraj 31975\/148, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","volume":"39","author":"Br\u00f6ker M.","year":"2011","unstructured":"Br\u00f6ker M.; Costantino P.; DeTora L.; McIntosh E.D.; Rappuoli R.; Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications. Biologicals 2011,39(4),195-204","journal-title":"Biologicals"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","volume":"28","author":"Shinefield H.R.","year":"2010","unstructured":"Shinefield H.R.; Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use. Vaccine 2010,28(27),4335-4339","journal-title":"Vaccine"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00795-011-0543-6","volume":"45","author":"Dateoka S.","year":"2012","unstructured":"Dateoka S.; Ohnishi Y.; Kakudo K.; Effects of CRM197, a specific inhibitor of HB-EGF, in oral cancer. Med Mol Morphol 2012,45(2),91-97","journal-title":"Med Mol Morphol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1002\/ijc.25472","volume":"127","author":"Yotsumoto F.","year":"2010","unstructured":"Yotsumoto F.; Oki E.; Tokunaga E.; Maehara Y.; Kuroki M.; Miyamoto S.; HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer. Int J Cancer 2010,127(11),2707-2717","journal-title":"Int J Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.bbrc.2012.05.052","volume":"422","author":"Tang X.H.","year":"2012","unstructured":"Tang X.H.; Deng S.; Li M.; Lu M.S.; The anti-tumor effect of cross-reacting material 197, an inhibitor of heparin-binding EGF-like growth factor, in human resistant ovarian cancer. Biochem Biophys Res Commun 2012,422(4),676-680","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1128\/aem.46.3.560-564.1983","volume":"46","author":"Rappuoli R.","year":"1983","unstructured":"Rappuoli R.; Isolation and characterization of Corynebacterium diphtheriae nontandem double lysogens hyperproducing CRM197. Appl Environ Microbiol 1983,46(3),560-564","journal-title":"Appl Environ Microbiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1128\/IAI.69.2.869-874.2001","volume":"69","author":"Miyaji E.N.","year":"2001","unstructured":"Miyaji E.N.; Mazzantini R.P.; Dias W.O.; Nascimento A.L.; Marcovistz R.; Matos D.S.; Raw I.; Winter N.; Gicquel B.; Rappuoli R.; Leite L.C.; Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin. Infect Immun 2001,69(2),869-874","journal-title":"Infect Immun"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1128\/IAI.67.8.4290-4294.1999","volume":"67","author":"Orr N.","year":"1999","unstructured":"Orr N.; Galen J.E.; Levine M.M.; Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA. Infect Immun 1999,67(8),4290-4294","journal-title":"Infect Immun"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jbiotec.2011.08.024","volume":"156","author":"Stefan A.","year":"2011","unstructured":"Stefan A.; Conti M.; Rubboli D.; Ravagli L.; Presta E.; Hochkoeppler A.; Overexpression and purification of the recombinant diphtheria toxin variant CRM197 in Escherichia coli.\n J Biotechnol 2011,156(4),245-252","journal-title":"J Biotechnol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1007\/s00253-016-7453-4","volume":"100","author":"Mahamad P.","year":"2016","unstructured":"Mahamad P.; Boonchird C.; Panbangred W.; High level accumulation of soluble diphtheria toxin mutant (CRM197) with co-expression of chaperones in recombinant Escherichia coli.\n Appl Microbiol Biotechnol 2016,100(14),6319-6330","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1128\/AEM.05259-11","volume":"77","author":"Prasad S.","year":"2011","unstructured":"Prasad S.; Khadatare P.B.; Roy I.; Effect of chemical chaperones in improving the solubility of recombinant proteins in Escherichia coli.\n Appl Environ Microbiol 2011,77(13),4603-4609","journal-title":"Appl Environ Microbiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ijbiomac.2020.11.212","volume":"167","author":"Dawn A.","year":"2021","unstructured":"Dawn A.; Deep S.; An improved strategy of TGF\u03b23 expression in Escherichia coli: Exploiting folding modulators for a switch from misfolded to folded form. Int J Biol Macromol 2021,167,787-795","journal-title":"Int J Biol Macromol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/0929866526666190930103552","volume":"27","author":"Bakhtiarvand B.","year":"2020","unstructured":"Bakhtiarvand B.; Sadeghi Z.; Tarahomjoo S.; Yaghmaie S.; Chaperones promote remarkable solubilization of Salmonella enterica serovar enteritidis flagellin expressed in Escherichia coli.\n Protein Pept Lett 2020,27(3),210-218","journal-title":"Protein Pept Lett"},{"key":"ref=14","year":"2011","unstructured":"pET system manual Novagen2011","journal-title":"pET system manual"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/B:JSFG.0000029237.70316.52","volume":"5","author":"Malakhov M.P.","year":"2004","unstructured":"Malakhov M.P.; Mattern M.R.; Malakhova O.A.; Drinker M.; Weeks S.D.; Butt T.R.; SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. J Struct Funct Genomics 2004,5(1-2),75-86","journal-title":"J Struct Funct Genomics"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pep.2005.02.004","volume":"42","author":"Zuo X.","year":"2005","unstructured":"Zuo X.; Mattern M.R.; Tan R.; Li S.; Hall J.; Sterner D.E.; Shoo J.; Tran H.; Lim P.; Sarafianos S.G.; Kazi L.; Navas-Martin S.; Weiss S.R.; Butt T.R.; Expression and purification of SARS coronavirus proteins using SUMO-fusions. Protein Expr Purif 2005,42(1),100-110","journal-title":"Protein Expr Purif"},{"key":"ref=17","author":"Myers R.H.","year":"2016","unstructured":"Myers R.H.; Montgomery D.C.; Anderson-Cook C.M.;  Response surface methodology: Process and product optimization using designed experiments 2016","journal-title":"Response surface methodology: Process and product optimization using designed experiments"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"W126-31","DOI":"10.1093\/nar\/gkm219","volume":"35","author":"Puigb\u00f2 P.","year":"2007","unstructured":"Puigb\u00f2 P.; Guzm\u00e1n E.; Romeu A.; Garcia-Vallv\u00e9 S.; OPTIMIZER: A web server for optimizing the codon usage of DNA sequences. Nucleic Acids Res 2007,35(Web Server issue)(Suppl. 2),W126-31","journal-title":"Nucleic Acids Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"Roy A.","year":"2010","unstructured":"Roy A.; Kucukural A.; Zhang Y.; I-TASSER: A unified platform for automated protein structure and function prediction. Nat Protoc 2010,5(4),725-738","journal-title":"Nat Protoc"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"W407-10","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"Wiederstein M.","year":"2007","unstructured":"Wiederstein M.; Sippl M.J.; ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007,35(Web Server issue)(Suppl. 2),W407-10","journal-title":"Nucleic Acids Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"ii246","DOI":"10.1093\/bioinformatics\/btg1086","volume":"19","author":"Ye Y.","year":"2003","unstructured":"Ye Y.; Godzik A.; Flexible structure alignment by chaining aligned fragment pairs allowing twists. Bioinformatics 2003,19(Suppl. 2),ii246-ii255","journal-title":"Bioinformatics"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1128\/jb.112.2.840-848.1972","volume":"112","author":"Lengeler J.","year":"1972","unstructured":"Lengeler J.; Lin E.C.; Reversal of the mannitol-sorbitol diauxie in Escherichia coli.\n J Bacteriol 1972,112(2),840-848","journal-title":"J Bacteriol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"744","DOI":"10.2174\/138920310794557727","volume":"11","author":"Melo E.P.","year":"2010","unstructured":"Melo E.P.; Estrela N.; Lopes C.; Matias A.C.; Tavares E.; Ochoa-Mendes V.; Compacting proteins: Pros and cons of osmolyte-induced folding. Curr Protein Pept Sci 2010,11(8),744-751","journal-title":"Curr Protein Pept Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1365-2958.2007.05705.x","volume":"64","author":"van den Bogaart G.","year":"2007","unstructured":"van den Bogaart G.; Hermans N.; Krasnikov V.; Poolman B.; Protein mobility and diffusive barriers in Escherichia coli: Consequences of osmotic stress. Mol Microbiol 2007,64(3),858-871","journal-title":"Mol Microbiol"},{"key":"ref=25","volume":"18-1134-37AC","year":"2007","unstructured":"GE-Healthcare, Rapid and efficient purification and refolding of a (histidine)6-tagged recombinant protein produced in E. coli as inclusion bodies. Application note 2007,18-1134-37AC","journal-title":"Application note"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1073\/pnas.87.8.2995","volume":"87","author":"Bruce C.","year":"1990","unstructured":"Bruce C.; Baldwin R.L.; Lessnick S.L.; Wisnieski B.J.; Diphtheria toxin and its ADP-ribosyltransferase-defective homologue CRM197 possess deoxyribonuclease activity. Proc Natl Acad Sci USA 1990,87(8),2995-2998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1100\/tsw.2002.215","volume":"2","author":"Fonda I.","year":"2002","unstructured":"Fonda I.; Kenig M.; Gaberc-Porekar V.; Pristovaek P.; Menart V.; Attachment of histidine tags to recombinant tumor necrosis factor-alpha drastically changes its properties. Sci World J 2002,2,1312-1325","journal-title":"Sci World J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2091-13-20","volume":"13","author":"Gr\u00f6nholm J.","year":"2012","unstructured":"Gr\u00f6nholm J.; Vanhatupa S.; Ungureanu D.; V\u00e4liaho J.; Laitinen T.; Valjakka J.; Silvennoinen O.; Structure-function analysis indicates that sumoylation modulates DNA-binding activity of STAT1. BMC Biochem 2012,13(1),20","journal-title":"BMC Biochem"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866529666220209155738","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200983\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866529666220209155738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T16:58:53Z","timestamp":1692896333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200983\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866529666220209155738","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}